Physician profile
Ryan Jeffery Batson
NPI 1407206071
$1,951.11
in general payments reported to CMS, 2019-2025
29 companies · $536 in 2025
The $536 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.80 · 2020: $29.81 · 2021: $244 · 2022: $307 · 2023: $387 · 2024: $433 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $329.05 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Coopersurgical, INC. | $218.30 | 2022-2024 | Summit Doppler, Endosee |
| Mayne Pharma Commercial LLC | $207.61 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $116.76 | 2023-2024 | Gemtesa, Myfembree |
| Myovant Sciences INC. | $116.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.44 | 2021-2025 | |
| Sage Therapeutics, LLC | $102.98 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $92.69 | 2023-2025 | Veozah |
| Pfizer INC. | $91.16 | 2021-2025 | |
| Exeltis, USA INC. | $72.63 | 2021-2025 | Slynd |
| Therapeuticsmd, INC. | $56.58 | 2021-2022 | |
| Organon LLC | $50.36 | 2024-2025 | Nexplanon |
| Scynexis, INC. | $38.66 | 2022 | |
| Dexcom, INC. | $31.90 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $31.26 | 2023-2024 | Gardasil 9, Gardasil |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $29.66 | 2024-2025 | |
| Sanofi Pasteur INC. | $26.15 | 2025 | |
| Applied Medical Resources Corporation | $24.67 | 2023 | |
| Supernus Pharmaceuticals, INC. | $23.70 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $21.83 | 2022 | |
| Axsome Therapeutics, INC. | $20.40 | 2024 | Auvelity |
| Exact Sciences Corporation | $18.17 | 2023 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $17.66 | 2022 | |
| Medtronic, INC. | $17.55 | 2023 | Ligasure |
| Optumhealth Care Solutions, LLC | $17.30 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Hologic Sales and Service, LLC | $17.08 | 2023 | Thinprep 2000 Processor, Aptima |
| Smith+Nephew, INC. | $17.08 | 2025 | Pico |
| Ethicon US, LLC | $16.18 | 2024 | Stratafix, Dermabond Prineo, Evarrest |
| Becton, Dickinson and Company | $15.10 | 2023 | Bd Onclarity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Batson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.